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Abstract 
Healthcare faces new challenges with automated medical support systems and artificial 
intelligence applications for personal care. The incidence of chronic diseases is increasing and 
monitoring patients in a home environment is inevitable. Heart failure is a chronic syndrome 
and a leading cause of death and hospital readmission on developed countries. As it has no cure, 
patients will have to follow strict medication plans for the rest of their lives. Non-compliance 
with prescribed medication regimens is a major concern, especially among older people. Thus, 
conversational systems will be very helpful in managing medication and increasing adherence. 
The Personal Medication Advisor aimed to be a conversational assistant, capable of 
interacting with the user through spoken natural language to help him manage information about 
his prescribed medicines. This patient centred approach to personal healthcare will improve 
treatment quality and efficacy. System architecture encompassed the development of three 
modules: a language parser, a dialog manager and a language generator, integrated with already 
existing tools for speech recognition and synthesis. All these modules work together and 
interact with the user through an Android application. 
System evaluation was performed through a usability test to assess feasibility, coherence 
and naturalness of the Personal Medication Advisor. It was concluded that the developed 
assistant could successfully make users achieve their objectives. In addition, the system was 
evaluated as easy to use, coherent and with a pleasant interface. Further improvements can still 
be done to extend the flexibility and convenience of the Personal Medication Advisor so that an 
easy integration on senior patient’s daily life can be achieved. 
 

  
Resumo 
Os cuidados de Saúde estão a ser revolucionados pela introdução de sistemas automáticos 
de suporte à decisão médica e outras aplicações de inteligência artificial. A incidência de 
doenças crónicas está a aumentar e torna-se inevitável monitorizar os pacientes em casa. A 
insuficiência cardíaca é uma síndrome crónica, sendo a principal causa de morte e readmissão 
hospitalar nos países desenvolvidos. Como não tem cura, os pacientes terão de seguir exigentes 
regimes de medição para o resto das suas vidas. O não cumprimento dos planos de medicação 
receitados é também uma preocupação, especialmente entre pacientes mais idosos. Assim, 
assistentes conversacionais poder-se-ão tornar muito úteis para gerir a medicação e aumentar a 
adesão aos planos prescritos. 
O Assistente Pessoal de Medicação procura ser um assistente conversacional capaz de 
interagir através de linguagem natural falada com o utilizador para o ajudar a gerir os seus 
medicamentos. Esta visão centrada no paciente pretende aumentar a eficácia e qualidade dos 
cuidados de Saúde. A arquitetura do sistema passou pelo desenvolvimento de três módulos: um 
processador de linguagem, um gestor de diálogo e um gerador de linguagem, integrados com 
ferramentas já existentes para reconhecimento e síntese de voz. Todos estes módulos atuam em 
conjunto e interagem com o utilizador através duma aplicação para Android. 
A avaliação do sistema recorreu a um teste de usabilidade para qualificar a performance, 
coerência e naturalidade do Assistente Pessoal de Medicação. O assistente desenvolvido 
conseguiu fazer com que os utilizadores atingissem os objetivos pretendidos. A aplicação foi 
também classificada como fácil de usar, coerente e com uma interface agradável. Futuras 
melhorias no sistema devem ser realizadas para aumentar a flexibilidade e conveniência do 
Assistente Pessoal de Medicação. Deste modo, será conseguida uma melhor e mais facilitada 
integração do assistente no dia-a-dia de pacientes idosos. 
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Chapter 1  
Introduction 
Health care technologies seem to be evolving towards interactive and personal health 
management assistants. Interaction with conversational assistants should be seen as an ongoing 
dialogue between user and system. Therefore, user’s intentions and goals must be understood 
by the system so that proactive help can be provided. Such technologies require a high level of 
system architecture as well as a complex coordination between its different components. This 
work intended to take another step on the direction of a Personal Medication Advisor (PMA), a 
conversational system capable of interacting with the user through natural language, mostly 
voice, to help him managing his prescribed medication regimens. This development was placed 
under the scope of a Dissertation project for the Integrated Master in Bioengineering at Faculty 
of Engineering of University of Porto and in association with Fraunhofer Portugal Research 
Center for Assistive Information and Communication Solutions (AICOS). 
This chapter firstly introduces the context, scope and needs behind conversational 
assistants for healthcare. Then, the motivation and objectives that supported the Personal 
Medication Advisor project are presented, as well as the requirements envisioned for the system 
and the anticipated benefits and innovative contributions of this research. Finally, the structure 
of this thesis is outlined. 
1.1 The problem 
As modern Medicine is developing, a large amount of pharmacological drugs continues to 
appear. The amount of money annually spent on medicines is growing exponentially (Sullivan, 
Behncke, & Purushotham, 2010). With the existence of so many drugs and possible medication 
regimens, Pharmacology brings a large amount of information to be managed by healthcare 
staff and patients. 
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While developed world population is aging, there are more demanding health care 
requirements so that elders can have quality of life. As age increases, the number of patients 
suffering from chronic illnesses is also raising (Giles, 2004). Heart failure (HF) is a common 
chronic disease with high prevalence and significant health expenditure due to frequent patient 
re-hospitalizations (Michalsen, König, & Thimme, 1998). Such diseases usually have numerous 
pharmacological prescriptions that require strict medication management. With complex 
medication regimens, patients spend a lot of effort gathering the information required to 
successfully manage their disease. Most of them even have trouble keeping track of this 
information. (Ferguson, et al., 2010) Due to unaffordable costs and insufficient medical 
personnel, healthcare staff cannot offer daily home-assistance. Therefore, there is a need of 
automated systems for health communication so that intelligence assistance can be provided to 
patients within a home health environment. 
Compliance is an important predictor of outcome among patients with chronic diseases 
like HF. As slight improvements in functional capacity are of the utmost importance to these 
patients, prescribed treatments should be taken seriously. Studies have shown that, in general, 
medication adherence is remarkably lower than self-reported adherence (Nieuwenhuis, Jaarsma, 
van Veldhuisen, & van der Wal, 2012). With this, it is also essential to maintain patient 
motivation and promote adherence to the pharmacological regimens in chronic patients. 
1.2 Motivation and objectives 
On the last decade, healthcare has arrived to the next stage of evolution with automated 
medical support systems and personal care applications (Topol, 2010) (Haux, 2006). The role of 
this work was to encompass this next technological step with a Personal Medication Advisor in 
harmony with Fraunhofer Portugal AICOS mission of Information and Communication 
Technologies for ‘care, well-being and inclusion’. 
Numerous pharmacological treatments rely on strict medication programs that should be 
complemented with lifestyle measures like dietary changes and appropriate exercise protocols. 
Therefore, conversational medical assistance may be very helpful, especially with chronic 
patients and elder healthcare. This work aimed to provide information and knowledge-based 
advice to help the user managing complex prescription regimens. Personalized intelligence 
assistance on posology, interactions, indications and adverse reactions will allow in-home 
medication monitoring. Since many patients do not recognize the value of strictly following 
medication regimens (Nieuwenhuis, Jaarsma, van Veldhuisen, & van der Wal, 2012), another 
objective includes motivating the user through interaction and dialogue, trying to increase 
medication adherence. 
The scope of the conversational assistant developed was restricted to medication regimens 
for heart failure. This syndrome was chosen due to its well defined pharmacological practices 
which greatly depend on self-care and self-management to lengthen patient survival. Since there 
is no cure for HF, patients will likely have to follow a medication plan for the rest of their lives. 
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Although expensive, existing HF home-monitoring programs have proved to be very helpful 
(Simon & Horowitz, 2002). A personal health assistant to interactively manage medication and 
prescriptions would help expanding monitoring access for HF patients by reducing healthcare 
costs, re-hospitalizations and number of face-to-face consultations. 
Dialogue systems for health communication generally aim to provide intelligence 
assistance to patients through spoken natural language conversation within a home health 
environment. Looking for this final achievement, the main goal of this project was to develop a 
modular system that would understand what the patient says and produce valid sentences, on a 
context of heart failure medication regimens, answering the user concerns. The integration of 
language understanding and generator modules with existing voice recognition and synthesis 
systems allows spoken interaction with the user. To complement this communication, 
information through images or text can also be available, but never as the main focus of the 
system-user interaction. 
1.3 Requirements 
As an agent-based spoken dialogue system, the Personal Medication Advisor mission tried 
to accomplish a ‘Remarkable Technology, Easy to Use’ motto. Under this thought, the PMA 
was built on the paradigms of consistency and simplicity where the generated sentences are 
intended to be short, direct and easy to understand. The goal was to make the system reliable, 
intuitive and portable. The system should not be too constraining, being at the same time easy to 
use. Because a decisive factor for adoption of technology is convenience (Jimison, et al., 2008), 
the system tried to require no special training for its utilization. The ultimate delivery to the 
consumers should be made using an everyday platform like the Android technology. 
Real-time generation is essential on a dialogue framework. With this requirement in mind, 
all the system modules had to be reasonably fast so that the PMA can be used on a real 
healthcare environment. Moreover, the generation had to be psycho-linguistically realistic and 
stylistically appropriated. Generated phrases must give useful information and advice on 
prescribed medication posology for heart failure scenarios. The outputted speech must be well-
formed, using formal but short and direct sentences. 
Taking these requirements in consideration, the medication assistant is settled to provide 
information on: 
• Posology - Information on drug administration methods and quantities. 
Subcategories of posology data include administration dosage, route, frequency, 
drug name and time references. This information on the drug-posology concept 
was classified as the most important and it should be incorporated during the first 
step of system development. 
• Drug indications - Specification of common targets and uses for a certain 
pharmacological drug. 
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• Adverse reactions - Information on the side-effects and harms of the usage of a 
pharmacological drug under the recommended administration conditions. 
A later and advanced approach to the Personal Medication Assistant should also manage 
contraindications, cautions and drug to drug interactions. 
The Personal Medication Advisor was developed in European Portuguese language, 
opening an unexplored path on the integration of intelligence assistance in Portuguese 
healthcare. 
1.4 Benefits 
The Personal Medication Advisor partially shares its beliefs with ‘Information therapy’. 
This methodology defends that providing specific evidence-based medical information to 
certain patients at the right time can help them making positive behaviour changes and improve 
self-consciousness of healthcare (Mettler & Kemper, 2003). The patient centred approach to 
health services seems to be a key to improve disease outcomes. Tailored health information and 
personalized health education are thus essential for effective healthcare (Jones, Cawsey, & 
Bentala, 1999). It is expected that the conversational assistant developed can bring together the 
advantages of information therapies and automated technologies, improving the effectiveness of 
health services, especially for people with chronic diseases or advanced age. Since chronic 
diseases, like HF, require strict and complex medications regimens, they are usually a potential 
menace to patient life and it was suggested that using automated intelligence assistance to 
manage medication could help in patient survival (Ferguson, et al., 2010). Therefore, it is 
anticipated that efficiency of healthcare services is enhanced by increasing patient survival, 
reducing re-hospitalization and mortality rates, diminishing complications and allowing a better 
responsiveness and distribution of work time for healthcare staff. Patients will also be able to 
live more independently with greater compliance and satisfaction with therapeutic regimens. 
The contribution of new technological solutions will surely lead to a pro-active attitude towards 
disease monitoring and management. 
1.5 Outline 
After presenting the aim, context and intents of the Personal Medication Advisor project, 
this thesis continues with Chapter 2, containing some background on heart failure, healthcare 
monitoring and conversational systems. The information presented is needed so that project 
context and design can be fully understood. The subsequent chapter, Chapter 3, identifies, 
characterizes and justifies the resources and tools used, opening the path to Chapter 4, where 
the PMA architecture, along with each module and feature, is explained in detail. Consequently, 
the evaluation performed and a discussion around the final prototype of PMA can be seen in 
Chapter 5, with special focus on the difficulties and challenges encountered. Finally, Chapter 6 
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presents a final balance of the five months of project development, concluding on what was 
achieved and what could still be done in the future. 
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Chapter 2  
Background and Literature 
Review 
In this chapter, a brief review of Heart Failure, healthcare technologies and conversational 
systems is presented. The provided background intends to face up to the aims and motivations 
of the Personal Medication Advisor, so that the final solution could be based on a systematic 
literature review. 
2.1 Heart Failure 
2.1.1. The Disease 
The European Society of Cardiology (ESC) defines Heart Failure (HF) as an “abnormality 
of cardiac structure or function leading to failure of the heart to deliver oxygen at a rate that 
fulfils the requirements of metabolizing tissues”. This syndrome is characterized by typical 
symptoms as fatigue, coughing, breathlessness or ankle swelling, and signs like pulmonary 
crackles, a third heart sound or elevated jugular venous pressure. There are several diagnostic 
methodologies available from essential tests as chest X-ray, electro- and echo-cardiogram to 
blood analysis, exercise testing and other imaging techniques (cardiac magnetic resonance, 
positron emission spectroscopy, cardiac computed tomography or coronary angiography). Even 
so, HF is often difficult to diagnosis, especially in early stages. Many of the symptoms are non-
specific and, thus, with limited diagnostic value. At the same time, many of the signs can result 
from congestion (i.e. sodium and water retention) being absent in patients following diuretic 
therapies. Precise identification of the cardiac problem is then crucial to determine the specific 
pharmacological therapy. Symptoms and signs are also essential to secure and monitor the 
response and stability of HF patients over time (European Society of Cardiology, 2012). 
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Heart Failure can be divided in systolic (HF-REF) or preserved (HF-PEF) according to the 
underlying cardiac abnormality and the left ventricular ejection fraction (EF). Other 
classifications of HF as acute or chronic can also be done. However, a detailed description of all 
types of HF does not serve the purpose of this work. As HF-REF is the best understood and 
most common type of HF (European Society of Cardiology, 2012), it will be the focus of this 
work.  
2.1.2. Aetiology & Epidemiology 
There are many possible triggers of HF, from diseases with potential to cause cardiac 
damage to certain nutritional behaviours or unhealthy lifestyles (Appendix A.I). HF is unusual in 
individuals with irrelevant medical history. Causes of this syndrome can also vary according to 
the world region and social environment (European Society of Cardiology, 2012). 
Similar statistics in Europe and USA associate primary diagnosis of chronic HF (CHF) 
with one million hospitalizations every year in each region (Heart Failure Association of the 
ESC, 2010). In Portugal, general prevalence of CHF in adults over 25 years old was estimated 
to be 4.36% in 1999 (Ceia, et al., 2004). Overall, 1-2% of the adult population in developed 
countries suffers from HF (European Society of Cardiology, 2012). This disease was identified 
as the leading reason for hospitalization in people older than 65 years. (Krumholz, et al., 2000) 
This age-related prevalence of HF is rising to more than 10% among persons older than 70 
years of age (European Society of Cardiology, 2012). 
2.1.3. Impact 
HF reality is described by high mortality, morbidity and a recently large increase in HF-
related healthcare costs in Europe (Heart Failure Association of the ESC, 2010). A study for 
UK showed that, in 2000, total HF-related healthcare expenditure were approximately £905 
million (1.078€ million), almost 2% of total National Health Service expenditure. Hospital stays 
and readmissions represented the major cost-component of expenditure related to the overall 
management of heart failure (Stewarta, et al., 2001). 
The development of HF symptoms and their worsening over time will unquestionably 
mean reduced quality of life for the patient with progressive declining of functional capacity. 
Frequent episodes of decompensation lead to recurrent hospital admissions and can even 
culminate in premature death. Before the existence of effective treatments, 60-70% of HF 
patients were often readmitted to hospital with worsening symptoms. With new 
pharmacological treatments appearing in the 90s, re-hospitalization was reduced in 30%-50% 
and mortality slightly decreased (European Society of Cardiology, 2012). 
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2.1.4. Pharmacological Treatments 
The ESC provides updated guidelines for diagnosis and treatment of HF-REF (European 
Society of Cardiology, 2012). Treatments aim to prevent or slow gradual worsening of the 
syndrome and assure patient survival. The ESC established three main goals for HF treatments: 
relieve of symptoms and signs improving quality of life, prevent hospital admissions and 
improve patient survival. Preventing recurrent hospitalization is important not only for the 
patients but also for healthcare systems. There are already effective pharmacological therapies 
to improve disease outcomes although they are not always successful. 
A treatment strategy for the use of drugs in patients with HF-REF is well-established and 
recommended worldwide. Three neurohumoral antagonists (an angiotensin-converting enzyme 
inhibitor or an angiotensin receptor blocker, a beta-blocker and a mineralocorticoid receptor 
antagonist MRA) are important to change the course of the disease and must be mandatory in 
every HF patient. Simultaneously a diuretic is used to relieve the symptoms and signs of 
congestion. Evidence states that these substances should be given to the patient as soon as 
possible after diagnosis (European Society of Cardiology, 2012). Reductions in mortality and 
hospitalization rates reflect the efficiency of treatments. 
 
• Angiotensin-converting enzyme (ACE) inhibitors 
This group of drugs causes dilation of blood vessels lowering blood pressure, reducing 
ventricular hypertrophy. They improve symptoms, quality of life and exercise tolerance and 
performance contributing also to reduce mortality rates. Occasionally, these drugs can worsen 
renal function and cause symptomatic hypotension, cough, hyperkalaemia and, rarely, 
angioedema. Due to these reasons, they are not used in patients with inadequate renal function 
and without a normal serum potassium level. If it is extremely necessary to give the drug to 
these patients, it is mandatory to consistently monitor renal function and serum electrolytes. 
Special attention is needed with the elderly. The most used ACE inhibitors are Enalapril, 
Ramipril, Captopril, Lisinopril and Trandolapril. 
 
• Angiotensin receptor blockers (ARBs) 
There are no longer many doctors that prescribe ARBs instead of ACE inhibitors. 
Currently, these drugs are used to substitute ACE inhibitors if patients are unable to tolerate 
them, especially due to cough or other of the already mentioned adverse reactions. If a MRA is 
not tolerable, ARB treatments can also be recommended. Candesartan, Valsartan and Losartan 
are some of the ARBs often used. 
 
• Beta-blockers 
These substances often have a substantial effect in improving the EF. They also have an 
anti-ischaemic effect, reducing the risk of sudden cardiac death. This is the main contributor to 
the reduction in mortality within one year of treatment. It should be used with caution in 
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patients after or during decompensation episodes where dose reduction may be necessary. The 
most common beta-blockers are Bisoprolol, Carvediol, Nebivolol and Metoprolol succinate. 
 
• Mineralocorticoid receptor antagonists (MRAs) 
MRAs inhibit sodium reabsorption in the kidneys interfering with sodium and potassium 
exchanges. The main MRAs are Spironolactone and Eplerenone, block receptors that bind 
aldestorone and other corticosteroids. It was shown that they have reduced mortality and 
hospitalization rates for patients after 2 years of treatment. Like the ACE inhibitors, they can 
cause hyperkalaemia and worsening of the renal function. Spironolactone can also cause breast 
discomfort and enlargement in men. 
 
• Diuretics 
They do not directly reduce HF mortality or hospitalization rates. These substances are 
only used to relieve congestion symptoms as well as achieve and maintain the ‘dry weight’ of 
the patient. The strength of the diuresis will depend on the dose, type of diuretic used and the 
patient renal function. Drug doses should be well-adjusted to avoid dehydration, hypotension or 
renal dysfunction. Based on daily weight, symptom and sign monitoring, some patients can be 
taught to self-adjust their diuretic dose at home. There are several classes of diuretics: from loop 
diuretics (Furosemide, Bumetanide or Torasemide) to thiazides (Bendroflumethiazide, 
Metolazone or Indapamide) and potassium-sparing diuretics (Amiloride or Triamterene). 
 
Common recommended dosages for the most common medications used to treat HF-REF 
patients are shown in Table 2.1. The ESC confirms that the usage rate of ACE-inhibitors, 
MRAs and beta-blockers is satisfactory. However, the number of patients treated with 
appropriate doses is still under the preferred level (Heart Failure Association of the ESC, 2010). 
There are other pharmacological drugs with lower levels of evidence for HF treatments. 
Usually, they are prescribed if ACE inhibitors and ARBs are not tolerated or if there are 
persisting symptoms despite the previous treatments. Examples of these drugs are Ivabradine, 
which slows the heart rate in some patients; Digoxin, a digitalis glucoside; H-ISDN, a 
vasodilator; and PUFAs, a group of n-3 polyunsaturated fatty acids. Most of them have shown 
reasonable benefits of symptom reduction proving to be useful alternatives or additional 
therapies. Other types of treatments for HF-REF are still in research so enough evidence can be 
achieved for their secure recommendation.  
Non-surgical treatment devices include wearable defibrillator vests or implantable 
monitors. Implantable cardioverter-defibrillators and cardiac resynchronization therapies are 
also possible treatments for HF-REF. For end-stage HF or other critical situations, surgery or 
even heart transplantation may be performed. 
The guidelines from ESC (European Society of Cardiology, 2012) also present indications 
on drugs that should be avoided because they may cause harm to patients with HF-REF. Drugs 
prescribed for co-morbidities may interact with the ones used to treat HF. Consequently, 
correctly managing co-morbidities and their medication is very important. Among the 
 Background and Literature Review 
12 
 
contraindicated drugs for HF patients that can worsen HF there are tricyclic antidepressants for 
depression, non-steroidal anti-inflammatory drugs for arthritis, thiazolidinediones for diabetes 
or drugs for hypertension. 
 
Table 2.1: Evidence-based doses of effective pharmacological drugs used for HF-REF 
(European Society of Cardiology, 2012). 
 
2.1.5. Living with Heart Failure 
As Heart Failure is a chronic disease with no cure, a new lifestyle must be adopted by the 
patients for the rest of their lives. Patients are advised to perform regular aerobic exercise as 
well as some diet restrictions. They have to avoid excessive fluid intake, prevent malnutrition, 
keep a healthy weight, and follow a sodium restriction. Essential behaviours, from no smoking, 
to alcohol abstinence and prevention of depression, must be present. Besides these concerns, 
patients have daily to monitor weight, blood pressure and heart rate. Other occurrences like 
sleep disturbances should also be taken in account. HF patients are taught to be vigilant of their 
condition and know when they should notify the healthcare provider. Urgent alterations on 
patient condition include rapid weight gain (more than 2kg in 3 days), increasing shortness of 
breath and constant oedema (fluid retention in the body) (European Society of Cardiology, 
2012). 
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2.2 Healthcare & Technology 
Follow up and daily monitoring has always been an important part of healthcare, 
especially for chronic diseases like HF. It was seen that close home monitoring by a nurse 
practitioner can help diminishing readmission rates for HF patients (Naylor, et al., 2004). The 
quality of healthcare seems to be correlated to the support that patients are given at home. With 
the objective of helping these caregivers, basic methodologies and new technologies allow 
easier health monitoring and successful self-management of medication. 
2.2.1   Basic Home-monitoring Tools 
From glucometers to cardiac health monitors encompassing a variety of wearable or 
implantable sensors, many tools have surfaced for home-monitoring of vital signs and 
conditions. Here, only the tools for monitoring medication or treatment plans will be briefly 
explored. 
Telemonitoring refers to the process of remotely monitoring patients who are not at the 
same location as the healthcare provider. Recent studies suggest that home telemonitoring 
appears to be particularly useful for patients with chronic heart failure, as the progressive 
deterioration of their clinical status and frequent re-hospitalisations constitute inevitable 
elements of the natural history of HF (Mortara, et al., 2009).  Structured telephone support and 
telemonitoring can help reducing CHF-related hospitalisations and the risk of mortality. Phone 
sporadic monitoring has already shown to improve disease outcomes (Grancelli H, 2003). This 
practice can be incorporated in other healthcare procedures enhancing quality of life, reducing 
costs and promoting evidence-based prescribing. Even though there are many advantages, 
telemonitoring practices are still blocked by technical, behavioural, managerial and financial 
barriers (Jimison, et al., 2008). 
Useful devices for managing medication include voice output devices. Voice prescription 
labels (VPL) or medication label readers are miniaturized electronic devices that offer audio 
information of prescriptions or medication (Allnatt, Engelhardt, Gao, & Mariano, 2001). They 
can take the form of pill boxes, medication dispensers, voice recorders or alarm watches. A 
physician or pharmacist has to record the information from the prescribed medication regimen. 
They are aimed especially for the elderly and visually impaired patients. The major advantage 
of these systems is their portability. Some of them have a medication reminder device 
incorporated. The overall objective of these technologies is to remind and prevent taking the 
wrong pill. ScripTalk (Raistrick, Phillip C; Raistrick, David; En-Vision America, 2006), 
Talking Rx (Millennium Compliance Corporation, 2004) and the MEMS 6 TrackCap (Aardex 
group, 2002) are examples of these devices. Nevertheless, their weakness lies in the fact that the 
device is not incorporated in something that the patient always carries with him. Furthermore, if 
the patient misses a dose, he still will not know what to do. Under a new approach, a recent 
patent presents Rx Zero (USA Patent No. US8303500, 2012), a non-pharmaceutical device to 
help prevent and monitor chronic diseases by managing, measuring, quantifying, monitoring 
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and motivating appropriate lifestyle behaviours for the patient. Even so, the lack of 
understanding of the disease and treatment as well as the cost of assistive technologies is the 
most significant barrier to the use of assistant technologies. 
2.2.2   Natural Language Generation Tools 
Tailored hypermedia information can be easily consulted by patients at home. These 
systems use artificial intelligence and natural language generation (NLG) techniques to generate 
personalized media with hypertext containing basic factual information about a certain patient 
medical record, disease and treatment. Depending on the method and the disease, the patient 
can have simple and cheap access to the information through different media being a leaflet, a 
webpage, an online questionnaire, an interactive application, etc. Among many others, PIGLIT 
(Patient Information Generated by Loosely Intelligent Techniques) (Binsted & Jones, 1995), 
HealthDoc (Hirst, DiMarco, Hovy, & Parsons, 1997), OPADE (Carolis, et al., 1996) and Patient 
Advocate (Miksch, Cheng, & Hayes-Roth, 1996) are examples of these systems. The objective 
of these systems is to ensure that patients have the information required to understand and 
manage their condition. On the other hand, some effort must be spent to design the knowledge 
database with the general medical information that may be communicated to the patient. 
Another noticeable problem of these tools is that a recommended drug for a particular disease 
appears once in the knowledge database but it may be mentioned in textual documents using 
many different surface forms. 
Artificial intelligence and NLG tools can be used on healthcare technologies on a more 
complex level: the conversational assistants. The Personal Medication Advisor fits within this 
class of systems that is still on an early stage of growth. Already developed or in-development 
conversational systems for home-monitoring or other medical applications are discussed in 
section 2.3.5. 
2.3 Conversational systems 
Conversational assistants are computerized systems that communicate and interact with 
human users to help solving problems. The conversational paradigm implies understanding a 
verbal input, through speech recognition and context understanding, as well as verbalizing a 
response, using language generation and speech synthesis (Seneff, 2003). This way the assistant 
can be engaged in dialogue with the user. A conversational assistant should focus on practical 
dialogues, meaning that both interlocutors are cooperating to perform a certain task and achieve 
a certain goal. Practical dialogues can comprise tasks from planning to management, 
information retrieval or advice-giving (Allen, Ferguson, & Stent, 2001). Different types of 
conversational assistance differ on the tasks to be performed, their complexity and the degree of 
initiative taken by both interlocutors. According to the balance of initiative on the conversation, 
it is possible to have directed, mixed-initiative or multimodal dialogues (Seneff, 2003). While 
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directed dialogue systems are already successfully commercialized, multimodal systems include 
action interaction and are starting to be developed. Mixed-initiative dialogue assistants are used 
for specific applications, usually staying as research prototypes. 
A brief and generalized representation of the structure of a conversational assistant is 
represented on Figure 2.1. Conversational systems are complex combinations of different 
modules. A division of dialogue systems can be made according to the role of each group of 
components: interpretation, behaviour or generation (Ferguson, et al., 2006). Interpretation or 
natural language understanding (NLU) modules capture and understand what the user said. 
Behaviour or dialogue management components plan system actions by managing goals, 
intentions and reasoning. Generation modules construct the dialogue through content planning 
and surface realization followed by speech output. 
When trying to assemble conversational technologies, there are four developing stages 
where attention should be focused, namely speech recognition, language understanding, 
language generation and speech synthesis (Cole, et al., 1996). 
 
Figure 2.1: Schematics of a typical conversational system with the different functional 
modules. Source: (Seneff, 2003) 
2.3.1. Speech Recognition 
Automated speech recognition (ASR) components capture and process spoken input by 
converting the acoustic signal to a set of words. Recognized words will then be used as input for 
analysis. Most ASR systems use statistical methods, neural networks and/or Hidden Markov 
Models for acoustic modelling (Jelinek, 1997). An ASR system usually consists of front-end, an 
acoustic model, a language model and a decoder (Figure 2.2). The system will depend on the 
intended type of recognition that can be, for example, speaker dependent or independent, 
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continuous or by isolated words. Spontaneous natural speech and its intrinsic variability can 
bring some difficulties to accurately recognize the speech. Variability in ASR lies on phonetic 
and acoustic dissimilarities as well as intra-speaker characteristics (age, emotional state, health, 
fluency or socio-linguistic background) (Benzeghiba, et al., 2007). Spoken input also differs 
significantly due to the false starts and filled pauses that characterize a natural speech. Even so, 
speech recognition systems have become much more robust in recent years with respect to both 
speaker and acoustical variability (Cole, et al., 1996). The system should be attentive for 
ungrammatical constructs, recognizing errors and modelling non-speech events and 
disfluencies. An extensive lookup on the available tools for recognition is made in Chapter 3. 
 
 
Figure 2.2: Overview of the structure of a typical ASR system. Source: (Neto N. , 2011) 
2.3.2. Language Understanding 
Between recognition and generation there is a NLU module to analyse and understand the 
acquired speech utterances. Encoded linguistic knowledge, like lexicon, grammar and 
semantics, helps producing a meaning representation or logical form through parsing and 
knowledge representation. The representation of the information acquired using adaptive 
models is of great importance, allowing it to be available afterwards for other applications 
(Cole, et al., 1996). Parsing establishes the syntactic organization as well as the semantic 
content of what was said. This is a hard task because subtle differences in phrasing and typical 
discourse constructions like ellipsis and pronominal or verbal referencing can lead to different 
interpretations. Ambiguities and ill-constructed sentences should be avoided by the system. 
Dialogue management tools are then responsible for clarification sub-dialogues, ambiguity 
dissolution and pragmatic considerations of what was said. The dialogue manager is the central 
unit for these tasks, generating and evaluating the hypotheses to the intended meaning of the 
user speech. After choosing the most possible intention of the user, the information is passed on 
to the next module presenting a hierarchy of active or pending goals and sub-goals. If the 
intention was not understood, the system should question the user. The dialogue manager 
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should also be responsible to update dialogue context on each iteration so that the system can 
always be well fitted in the conversation (Traum & Larsson, 2003). 
2.3.3. Language Generation 
Natural language generation (NLG) refers to the process of automatically converting an 
abstract meaning representation into a string (Baptist, 2000). NLG aims to produce high-quality 
natural language text from computer internal representations of information. 
2.3.3.1  Processes 
There are several different approaches to language generation. Generation processes can 
be mainly categorized as non-linguistic (being statistical, canned-text or template-based 
systems) or as linguistic (being phrase-based, MTT-based or feature-based systems) (Baptist, 
2000). The shallow simplicity of non-linguistic generators opposes to the sophistication of 
linguistic approaches that require much more planning and development. In general, linguistic 
methods are more robust and present high quality output. Linguistic generators entail 
simultaneous computational and linguistic knowledge relying on linguistic knowledge 
databases (LKB), this is, sets of files comprising grammar rules, lexical entries and rewrite 
rules, which specify the generation domain. 
A statistical NLG system depends on training and probabilistic models that can be more or 
less complex (Ratnaparkhi, 2000). Although these systems are fast, they lack in accuracy and 
flexibility. Canned-text generators are the simplest but most wasteful systems. They only 
produce a static string of words without any amend, adequate for periodic event-specific 
generation (Cole, et al., 1996). More sophisticated, template-based systems can introduce minor 
alterations on generated sentences while a major part of the text is still static. Unlike previous 
approaches, they can perform multi-sentence generation if the text has a rather constrained 
structure (Reiter, NLG vs. templates, 1995). 
Phrase-based systems focus on text planning by using generalized templates and replacing 
phrasal patterns by selected words. Their robustness works at sentence or discourse level 
(Hovy, Planning coherent multisentencial text, 1988). However, their weakness lies on the 
shortage of text plan libraries and on the complex phrasal interrelationships present at longer 
discourses, not fitting real scenarios. Meaning-text theory (MTT) based generators sequentially 
map semantic, syntactic, morphological and phonetic levels of representation according to a set 
of rules. The description of these relationships is made using lexical functions (Goldberg, 
Driedger, & Kittredge, 1994). With feature-based systems, each possible alternative of a 
language expression is analysed and categorized in a feature. As consequence, each sentence is 
characterized by a particular group of features. The final sentence is determined by 
incrementally match each inputted phrasal segment to the suitable feature. For these systems, 
the interrelationships are still difficult to manage and the number of features that can be 
 Background and Literature Review 
18 
 
identified must be controlled. There are no multi-sentence featured-based generators (Hovy, 
Language generation, 1996). 
NLG was effusively studied between the late 1980s through the 1990s. Initially, simpler 
approaches like statistical or canned-text systems were preferred. However, over the years, 
there was acceptance of template-based and, later, of linguistic generators (Baptist, 2000). 
Integration of template-based and linguistic approaches would be suggested by Ehud Reiter 
(Reiter, NLG vs. templates, 1995), in 1995, opening a path to hybrid generation systems. 
Within a hybrid framework, encompassing both linguistic and non-linguistic aspects may 
present interesting advantages, allowing either to rapidly develop tools for simple domains or to 
use expert knowledge bases for more challenging domains (Baptist, 2000). The arrival of 
machine learning techniques after the mid-1990s has allowed further studies on linguistic 
approaches, mainly on sentence planning (Walker, Rambow, & Rogati, 2001), lexical selection 
(Bangalore & Rambow, Corpus-based lexical choice in natural language generation, 2000), 
word order (Bangalore & Rambow, Exploiting a probabilistic hierarchical model for generation, 
2000) and grammatical relations (Corston-Oliver, 2000). Stochastic approaches and machine 
translation are bringing many advances to NLG (Chambers & Allen, 2004). With this, new 
hybrid methodologies appeared, namely the corpus-based stochastic generation where linguistic 
models are combined with statistical models derived from annotated corpora (Oh & Rudnicky, 
2002). 
2.3.3.2  Tasks 
A modular approach to NLG is helpful so the developer can first be focused in managing 
and testing each of the three central tasks that comprise the generation process (Hovy, 
Language generation, 1996).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Overview of the tasks of a generation module. Source: (Dale, 1995) 
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Then, all the task responsible modules should be assembled and their communication 
assessed. Different models for the NLG system architecture and interconnection can be found 
(one example is presented on Figure 2.3). Although not completely independent, each 
generation task is briefly presented. 
• Text planning or content determination 
This first step defines global text structure, deciding what to say. The inputted information 
is mapped, the text content is established and the information organized accordingly. There are 
several approaches to text planning as the traditional top-down planners using Rhetorical 
Structure Theory (Hovy, Planning coherent multisentencial text, 1988) or intentional operators 
(Moore & Paris, 1993). 
• Sentence planning 
The information is structured and ordered into sentences and paragraphs using appropriate 
reference words as conjunctions and pronouns. Common tasks include pronoun specification, 
focus signalling, content aggregation to remove redundancies and preliminary phrase ordering. 
Lexicalization, the transition from concepts to lexical representations, can be included within 
this task. The lexical choice includes collocations and definition of lexical sub relations 
(Busemann, 1993). This module is thus seen as a mediator between deep generation (text 
planning) and surface realization because it limits simultaneously what can be said and how it 
can be said. Even so, a clear division between this and the other NLG modules is not always 
very visible (Smedt, Horacek, & Zock, 1996), 
• Surface realization or surface generation 
Using grammar knowledge, coherent and grammatically correct sentences are produced in 
formatted output text. The realization of the planned expressions, determines how to say the 
information according to morphological and phonological rules. Computational models try to 
mimic human utterances to approach the output to natural speech. A common approach is the 
stochastic surface realization: language models are built, candidate utterances are generated and 
scored, the best utterance is selected and finally the missing slots are filled with the relevant 
input information (Oh & Rudnicky, 2002). 
2.3.3.3  Demands of language generation 
Developing a NLG system requires good structured lexicons and grammars in the 
language(s) that the system will use; knowledge bases oriented to the domain-specific 
application that is being developed and consolidated text planning libraries. Appropriate text-to-
speech and speech-to-text systems would be necessary to help integrating the NLG module on a 
conversational system. Naturalistic speech generation with the inherent disfluencies, 
interruptions or overlaps is still distant   due to the unsolved difficulties related to discourse and 
interpersonal speech variability. 
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Until now, only general purpose single-sentence or limited purpose multi-sentence 
generators were developed (Hovy, Language generation, 1996). A multimodal general purpose 
language generator has not been build due to the unsolved problems that appear when using 
large lexicons, unclear contexts, unconventional discourse structures, large-sized domains or 
systems with great expressive potential that can say the same thing in many ways. In this way, 
there is still a lot of work to be done on developing generators with the desirable coherence and 
consistency, producing texts of several paragraphs functional on real-world domains. 
Challenges arise when trying to build multilanguage systems. As the major amount of 
NLG research is done using English language, generation in Portuguese is still poorly explored. 
Furthermore, European Portuguese has a complex verbal structure with auxiliary verbs 
(Baptista, Mamede, & Gomes, 2010). For now, more literature can be found on Portuguese 
language recognition, parsing and processing (Meinedo, Caseiro, Neto, & Trancoso, 2003) 
(Silva, Branco, Castro, & Reis, 2010) rather than on Portuguese NLG. 
2.3.4. Speech Synthesis 
Speech synthesis is the automatic generation of speech waveforms. Spoken output of NLG 
sentences can be produced by text-to-speech (TTS) systems (Figure 2.4). The first speech 
synthesis systems were hardware-based. With the increase of computational power, today’s 
synthesizers are mostly software-based, allowing more functionalities, more flexibility and 
frequent updates (Lemmetty, 1999). In the majority of TTS systems, the first step is text 
analysis, or high-level synthesis, where a grapheme-to-phoneme conversion is done. Character 
strings are pre-processed and converted into phonetic representations. These representations are 
typically a string of phonemes that can also contain information about phasing and intonation. 
On a second phase, called low-level synthesis, phonemic representations are converted to 
waveforms that can be outputted as sound. The majority of actual systems are composed of both 
high and low synthesis components. 
 
Figure 2.4: Overview of the structure of a typical TTS system. Source: (Vasavi & Sravya, 
2010) 
 
There are several methodologies for generating synthetic speech waveforms: from 
concatenative to articulatory, formant or Hidden Markov Model based synthesis. (Lemmetty, 
 Background and Literature Review 
21 
 
1999) Each TTS system uses one of these methods according to its own strengths and 
weaknesses and the intended use of the system. Concatenative TTS systems require pre-
recorded units and sound libraries based on human speech recordings. With this, they provide a 
synthesized speech with a more natural sound. This naturalness implies the transcription and 
alignment of large corpora, what can be time-consuming and demand a profound knowledge of 
phonetics to accurately align temporally the transcription labels (Carvalho, Oliveira, Viana, & 
Trancoso, 1998). Formant TTS systems are rule-based requiring less resources. Although the 
voice quality is lower and less natural, the speech is clear and many languages can be provided 
with a small size system. This may also make these systems faster than concatenative TTS. 
Modern speech synthesis technologies involve complex methods and algorithms. Among recent 
approaches to speech synthesis, Hidden Markov Models and Neural networks based 
methodologies are very used (Schroeder, 1993). 
TTS engines also differ with different languages, dialects and specialized vocabularies. 
High quality speech synthesis systems should maximize naturalness and intelligibility 
(Lemmetty, 1999) (Thakur, Chettr, & Shah, 2012). The current speech synthesis systems can 
already artificially produce highly intelligible human speech. However, achieving an optimal 
naturalness with synthesized speech can still be a problem (Cole, et al., 1996). An overview of 
existent TTS tools is available in Chapter 3. 
2.3.5. Current Conversational Systems 
A majority of the existing conversational assistants is available for profitable applications. 
They include flight booking assistants, weather informers, restaurant or hotel guides, calendar 
managers, city navigators, traffic reporters, sports updaters, crisis supervisors, among others 
(Seneff, 2003). After several years of development in MIT, Genesis II is an example of a hybrid 
conversational assistant presenting a framework for several languages and several domain 
applications: from JUPITER in weather domain to MERCURY in flight reservation, ORION in 
off-line task delegation or VOYAGER in navigation assistance (Baptist, 2000). Amalgam was 
developed by Microsoft focusing on sentence realization and using machine-learned and 
knowledge-engineered modules in machine translation contexts (Gamon, Ringger, & Corston-
Oliver, 2002). Other systems include the IBM Flight Information System, (Axelrod, 2000) the 
CMU’s statistical generator (Jin, 2003) and a collaborative multimodal system for rescue 
emergency scenarios TRIPS (Allen, et al., 2001). These systems are usually based in English, 
German, Japanese and/or French Language generation. Research on European Portuguese NLG 
and conversational systems is still limited. Meteo (Cardoso, Flores, Langlois, & Neto, 2002), a 
telephone-based conversational system for weather forecast and the spoken dialogue virtual 
butler of the Interactive Home of the Future project (Neto & Cassaca, 2004) are examples of the 
few conversational systems developed in European Portuguese. 
Medicine related systems started to appear on the last decade. An example of surgery 
applications for NLG and intelligent assistance is GALEN-IN-USE system for the collaborative 
construction and maintenance of surgical procedure classifications (Wagner, Rogers, Baud, & 
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Scherrer, 1999). Conversational assistants using NLG for healthcare are still in development 
like the Chester (Ferguson, et al., 2006) and CARDIAC (Galescu, Allen, Ferguson, Swift, & 
Quinn, 2009) systems. The CARDIAC is an English spoken dialogue system that conducts 
health monitoring interviews using natural language for chronic heart failure patient healthcare. 
Rather than medication assistance, it collects information about the current state of patient’s 
health from objective (weight) to subjective (pain, fatigue, exercise) conditions. CARDIAC can 
be useful for patient self-care, for monitoring trends and generating reports for healthcare 
providers. In a way, it shares part of its motivations with the Personal Medication Advisor. 
New and more complex approaches have appeared, using NLG and speech along with 
sensing, acting and gesture recognition to assemble multimode robot systems in what is called 
an Embodied or Situated Conversational Assistant (Mavridis, 2007). They include robotic lab 
assistants, household helpers and affective robotic computers. They may portray the future of 
conversational assistant technologies. 
2.4 Summary 
Over this chapter, the motivation and problem behind this project was further 
contextualized by characterizing the world-wide Heart Failure healthcare scenario. Heart 
Failure is a disease with increasing incidence associated with high hospitalization costs, high 
mortality and morbidity. These patients need to follow strict medication regimens, composed of 
ACE inhibitors, ARBs, MRAs and beta-blockers, to reassure their survival and reduce 
rehospitalisation. Daily home-monitoring and medication compliance are extremely important 
for HF patients. There are several home-monitoring tools they can use. 
Conversational assistants can be encompassed within a HF home-healthcare environment. 
The main tasks of a conversational system are to understand what the user says, to plan an 
appropriate response and to express a response to the user through generated natural language. 
Thus, these systems usually have a modular structure, with modules for speech recognition, 
natural language understanding, dialog management, natural language generation and speech 
synthesis.
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Chapter 3  
Tools and Resources 
This chapter identifies the resources and tools that were exploited along the different steps and 
iterations of the Personal Medication Advisor. Although some of these tools are not directly 
used by the final prototype, they played an important role during the development process. 
With this, development platforms are pointed up, followed by the resources and tools that 
were necessary to this project. From speech technologies to the linguistic tools used, an 
explanation of their characteristics, purpose and the rationale for their choice is given. 
3.1. Development platforms 
During an initial phase, the medical assistant was developed for personal computers, using 
Java in the Eclipse environment. Java was chosen as the programming foundation of PMA 
because it is simple, portable, free-ware, allows easy integration of external packages and 
supports modular programming. Even so, the most important reason was to facilitate the 
integration of the system with Smartphone technologies. Consequently, at a later stage, PMA 
was rebuilt as an Android application, using Java and the Eclipse IDE bundled with Android 
Development Tools (ADT). 
3.2. Resources 
3.2.1 Ontologies 
The required medical information regarding medication posology, dosage, indications and 
adverse reactions, among others, was retrieved from an ontology. An ontology can be defined 
as ‘a formal, explicit specification of a shared conceptualization’ (Studer, Benjamins, & Fensel, 
1998), this is, a model of a certain system that takes the form of a definition of properties of its 
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important entities and relationships, being specified in an unambiguous language and 
processable by both machines and humans (Staab & Studer, 2009). With this, an ontology is 
characterized by well-defined syntax and semantics, efficient reasoning support, sufficient 
expressive power and convenience of expression. The final objective is to provide a meaningful 
shared vocabulary by presenting customized concepts and properties along with their 
definitions and constrains, so that it can be used for domain specific communication between 
people and information technology (IT) systems. Ontologies are usually designed through 
XML-based or web semantic languages such as resource description framework (RDF) or the 
expressive Web ontology language (OWL). This type of resources is now essential to many 
applications such as scientific knowledge portals, information management, electronic 
commerce or semantic web services. 
 
Figure 3.1: Tree of entities, types and subtypes for the PharmInx ontology. Source: (Aguiar, 
2012) 
The OWL based ontology used as the knowledge resource of PMA was created through 
the PharmInx (Pharmacological Information Extraction) system under the context of another 
project at Fraunhofer (Aguiar, 2012). This system arose from the need of having a methodology 
to design a complete, well-defined and reliable medical vocabulary that would be shared 
between computational systems, healthcare application users and professionals. Hereby, 
PharmInx comprises automatic extracting and modelling of information from Portuguese 
medical therapeutic records and leaflets. This tool was mainly developed to extract posology 
information using extensible knowledge models, structuring entities and their respective 
relations extracted from pharmacological texts. A representation of the entities and types of the 
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PharmInx ontology can be seen in Figure 3.1. Several methods are used for the extraction and 
structuring of information, from regular expressions to external information sources’ lookup or 
machine learning techniques. Extraction from free-form text written in Portuguese and 
automatic population of the ontology with the information extracted were achieved with high 
precision when extracting posology. The PharmInx ontology was thus designed and maintained 
resorting to the Protégé framework, whereas ontology’s population performed with JENA API. 
The PMA will also make use of these two tools, presented in detail on the next section. Even so, 
PharmInx was not able to extract all kinds of pharmacological information. This could have 
confined the ontology that was used and consequently constrained the information that PMA 
could use. 
An organized and structured representation of medical information is thus available in 
European Portuguese. The Personal Medication Advisor used this knowledge representation 
model, restricting it to the heart failure pharmacology domain. The fact that PMA is based on 
ontology knowledge is a strong uniqueness of this project. 
3.2.2 Linguistic resources 
As a conversational system, PMA is very dependent on linguistic resources like European 
Portuguese LKBs and domain specific lexicons. Linguateca (Monteiro, et al., 2008) is a 
resource centre for computational processing of the Portuguese language which provides useful 
materials for linguistic analysis and processing. Along the development process, several 
language resources were tried out, namely some domain independent Portuguese dictionaries 
and lexicons. These resources were needed for language processing and generation. As the 
system was adapted to the Android platform, the linguistic resources were modified and 
restricted to a domain specific vocabulary so that the system required less memory and had a 
faster performance. 
3.3. Ontology tools 
3.3.1 Jena 
Jena is a Java programming framework for ontology applications development, handling 
RDF, OWL and SPARQL (SPARQL protocol and RDF query language) (The Apache Software 
Foundation). It is an open-source project started in 2000 by HP Labs and maintained by The 
Apache Software Foundation. 
The Jena application programmatic interface (API) allowed reading and modelling the 
ontology as well as searching and retrieving the desired information through SPARQL queries. 
SPARQL is a query language to retrieve and manipulate data stored in the RDF format. When 
used along with Jena API, these queries were very helpful since they allowed retrieving from 
the ontology the specific information to answer a certain question asked by the user. 
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3.3.2 Protégé 
Protégé is another Java based tool, useful for working with ontologies. It is an open-source 
project by the Center for Biomedical Informatics Research at Stanford University (Stanford 
Center for Biomedical Informatics Research). It works as a platform for ontology creation, 
editing and visualization. It has a user friendly interface and it also supports a variety of 
ontology formats such as RDF, OWL and XML Schema. Protégé is an extensible and 
customizable framework that can be easily integrated with other systems. 
As the ontology that was used was already created and modelled, Protégé was used mostly 
for visualization of ontology individuals and their relationships. An example of an ontology 
individual and its properties in Protégé is shown in Figure 3.2. 
 
 
Figure 3.2: Individuals view for the PharmInx ontology on Protégé. 
3.4. Language tools 
Part-of-speech taggers and phrase chunkers are crucial for natural language processing. 
They divide phrases and annotate, for each word in the text or sentence, its corresponding part-
of-speech, this is, its lexical category. JTextPro and TreeTagger are open-source linguistic tools 
that were used for language processing in the PMA project. 
3.4.1 JTextPro 
One part-of-speech tagger for English can be JTextPro (Phan, 2006), a Java based toolkit 
for text processing, developed in Tohoku University. It can effectively perform word 
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tokenization, phrase chunking and part-of-speech tagging for English texts. This tool was used 
for the initial stage of the project that used the English language as it will be later explained. It 
presents a good performance, with successful tagging. 
3.4.2 TreeTagger 
TreeTagger is a language independent part-of-speech tagger that has been successfully 
used to tag many languages including English and Portuguese. For each word, it identifies the 
word class (part-of-speech) and the lemma. TreeTagger uses decision trees, instead of the 
popular Markov Models, achieving good precision rates. It was developed by Helmut Schmid 
for the TC project at the Institute for Computational Linguistics of the University of Stuttgart 
(Schmid, n.d.). For better results, each language should work with a specific parameter file 
containing a trained corpus. European Portuguese parameter file was developed by Pablo 
Gamallo of University of Santiago de Compostela (Otero, 2005). Tagging for Portuguese 
achieves good results with TreeTagger. 
3.5. Speech tools 
Voice technologies consist of speech synthesizers and recognizers, being key tools for 
natural spoken human-computer communication. Both synthesis and recognition modules are 
not the main focus of this work but rather tools to allow the development of the conversational 
assistant and implementation of Natural Language Understanding and Generation techniques. 
Nevertheless, recognition and synthesis platforms had to be carefully chosen so that integration 
with PMA’s NLU and NLG modules could be successfully achieved. As these tools presented 
some constrains to system development, early selection of these components was 
recommended. It is also important to note that quality and accuracy of both synthesis and 
recognition are not the most important factors when choosing the speech tools to use for this 
project. With this, the proposed requisites for selecting speech tools were: 
• Have an European Portuguese language and acoustic models; 
• Be written in Java or support Java Speech API by Sun Microsystems Laboratories; 
• Be free-ware; 
• Be portable; 
• Allow specialized medical vocabulary; 
• Have acceptable quality and accuracy. 
Speech synthesis research started even before the digital revolution, when Homer Dudley 
presented Voder and Vocoder, in 1939 and 1940, at Bell Telephone Laboratories, being the 
initial attempts to electronically mimic human speech (Dudley, 1939). The first automated 
speech recognition tools were also developed at Bell Laboratories (the "Audrey" system) later 
in the 50s (Davis, Biddulph, & Balashek, 1952), followed by RCA Laboratories (Olson & 
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Belar, 1956) and MIT Lincoln Lab (Forgie & Forgie, 1959) systems. But it was only during the 
80s that speech research prospered and, as technical limitations diminished, new opportunities 
were brought to speech technologies. 
3.5.1 TTS systems 
There is a long list of TTS systems, from open source to commercial ones, from 
discontinued to in-development products, from commonly used to unheard of systems. Some 
examples are Ximera by ATR Interpreting Telecommunications Labs, IVONA by IVONA 
Software, DECtalk by Digital Equipment Corporation, Infovox by Acapela group, Natural 
Voices by AT&T labs, ORATOR by Telecordia, CyberTalk by Panasonic, Vocalizer by Nuance, 
HERON by University of Aveiro and much more. The synthesizers FreeTTS by Sun 
Microsystems Laboratories, Festival by CSTR University of Edinburgh, FurbSpeech by 
Germano Fronza and Israel Medeiros and eSpeak by Jonathan Duddington were selected as 
possible candidates to integrate in PMA. These systems were evaluated according to the 
established requirements. 
If the PMA was to be set with the English language, Festival or FreeTTS would be a good 
choice. Festival is one of the most complete free-ware TTS. It offers diphone concatenation 
synthesis through several APIs, being a general framework for building speech synthesis 
systems (Black, Taylor, & Caley, The Festival speech synthesis system: system documentation, 
2001). This synthesizer is written in C++ and supports Java Speech API (JSAPI). It is a good 
TTS system although it can be a bit slow due to its size. FreeTTS (Sun Microsystems Inc., 
2005) is another TTS system that can be used for English. It is written in Java and was derived 
from both Festival and Flite. The project Personal Health Management Assistant from 
University of Rochester is similar to the PMA and used FreeTTS to generate speech (Ferguson, 
Personal Health Management Assistant, 2007). eSpeak (Free Software Foundation Inc, 2007) 
also seemed to be a good system, with the advantage that it already presents a model for the 
Portuguese language. However, it is written in C and does not support JSAPI. eSpeak uses 
formant synthesis while FreeTTS and Festival use concatenative synthesis and generate a more 
natural speech. 
During the early development of PMA, that used using American English as language, 
synthesis was performed with FreeTTS. Speech output was fairly good and robust, although a 
bit slow sometimes. 
For European Portuguese, there are a few synthesizers available but they are mostly 
commercial products. As we want to develop a freeware-based conversational system in 
European Portuguese, using FreeTTS or Festival would require building a new model with 
Festvox. There were no freely available and robust acoustic and language models for European 
Portuguese to integrate with the synthesizer. Models and voices for Portuguese could be 
generated using FestVox or other voice building tool. This would be another great challenge, 
but beyond the scope of PMA. Synthetic voice building is time-spending, calls for processing 
power and requires recording a fairly big sound database. To obtain a good voice model, 
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training techniques for intonation, duration modeling and letter-to-sound rules are also 
necessary (Black & Lenzo, Building Synthetic Voices, 2007). 
Synthesis in PMA was then achieved by conjugating FurbSpeech, a TTS API developed 
for Brazilian Portuguese (Fronza & Medeiros, 2009), with MBROLA voices (Dutoit, Pagel, 
Pierret, Bataille, & Vreken, 1996). Both Brazilian and European Portuguese MBROLA voices 
were used. The speech generated with each one of the three available Brazilian Portuguese 
voices was better and more understandable than the European one. The European Portuguese 
voice used was the only MBROLA voice available for this language and it lacks in naturalness, 
having particular problems in the synthesis of phonemes that contain 'nh', 'lh' or 'j'. Furthermore, 
with both Portuguese voices there are still some difficulties when synthesizing words with 
accentuation or special characters like 'ç'. 
3.5.2 ASR systems 
There are less ASR than TTS systems. Some recognition tools include: Via Voice by IBM, 
Dragon Naturally Speaking or Nuance Recognizer by Nuance, Julius by Nagoya Institute of 
Technology, Windows Speech recognition technologies by Microsoft, Tazti by Voice tech 
group, AUDIMUS by INESC-id and Natural language recognition tools by Simplis. 
A big difficulty of the PMA project has been the choice of recognition tools for 
Portuguese. Recognition in European Portuguese is still undeveloped and very new. An ASR 
tool that could fulfil the requirements was CMUSphinx (Carnegie Mellon University, n.d.). 
Sphinx4 is Java written and allows building and incorporating language models. It is a flexible 
system. It has been used for several applications including the Personal Health Management 
Assistant from University of Rochester (Ferguson, Personal Health Management Assistant, 
2007). The early version of PMA used Sphinx to recognize in English, having a predefined and 
auxiliary Java Speech Grammar Format (JSGF) that defined possible user utterances to be 
recognized. Sphinx recognition worked very well for American English. The use of an 
appropriate model should allow adapting this system for recognition in Portuguese. However, 
there are no free acoustic models or grammars for European Portuguese. With this, other 
alternatives were explored. One solution could encompass using JlaPSAPI, a Brazilian 
Portuguese specification of JSAPI for recognition with Java. This API is still under 
development, very user unfriendly and needs several external packages and installations. Other 
solution was combining Sphinx with a PMA specific grammar and existing Brazilian 
Portuguese dictionaries and language models. Due to the lack of acoustic training and the 
difference between European and Brazilian Portuguese accents, the accuracy of recognition 
seemed insufficient for this solution. The problem of ASR for European Portuguese could only 
be surpassed when the PMA project moved to the Android platform and made use of android 
speech tools. 
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3.5.3 Combined systems 
There are systems were both TTS and ASR systems are embedded and combined: from the 
successful Google Now by Google or Siri by Apple to LumeVox speech engine by Lumevox or 
Loquendo TTS and ASR by Nuance. For example, Zanzibar openIVR by SpokenTech uses 
FreeTTS and Sphinx4 and goes to the encounter of the tools chosen above. Nevertheless, most 
of these products are only commercially available for user-end purposes and not for developers. 
Among them, iSpeech technologies (iSpeech, n.d.) have demo versions that are available for 
Java and mobile environments and were tested with PMA. The synthesis in European 
Portuguese has very high quality and is very accurate. Unfortunately, speech recognition on the 
demo version is limited and synthesized speech sometimes includes a copyright marking in Java 
developing environments. 
 
It was only during the latest phase of development, when PMA moved to the Android 
implementation, that the best arrangement of speech recognition and synthesis tools was found. 
Android speech recognition packages, Google Voice (Google, n.d.), were used as they worked 
better than iSpeech Android recognition. On the other way, iSpeech Android synthesis had more 
quality than Android speech synthesis and thus was preferred. 
3.6. Summary 
The platforms essential to the development of the project were described in this chapter. In 
summary, the Eclipse IDE bundle with ADT was the final platform of choice. The resources 
used included a medical domain specific ontology, obtained through the systematic processing 
of Portuguese medical leaflets, as well as European Portuguese languages resources such as a 
dictionary and a domain specific lexicon. 
The tools used comprise Java frameworks for ontology modelling, visualization and 
questioning, in addition to language processing packages for part-of-speech tagging and phrase 
chunking. Among the several speech technologies that were assessed, there was a special focus 
in CMUSphinx and Google Voice for ASR, as well as FreeTTS, FurbSpeech and iSpeech for 
TTS. 
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Chapter 4  
The Personal Medication Advisor 
The Personal Medication Advisor was envisioned to be developed within an iterative patient 
centred approach for personal healthcare. During the whole process of development, the system 
aimed for consistency, simplicity and full applicability on home health environments, namely 
for heart failure care. 
This chapter describes each step of implementation and development, along with an 
explanation of system architecture. First, a general overview of PMA’s features and 
performance is given. Then, the final architecture of PMA, along with descriptions of module 
tasks, is clarified. Main features and guidelines of system architecture are shared by the 
different PMA prototypes during the different stages of the project. For this reason, the 
distinction between the different prototypes and stages is only given afterwards. 
4.1. General overview 
Before a detailed analysis of system architecture and of the different stages of 
development, a brief overview of system flow and functionalities of the system is needed. 
PMA engages the interaction with the user by generating a greeting according to the time 
of the day (morning, afternoon or night) and then waits for a user utterance. Due to the 
complexity of coherent and complete conversational systems, the range of possible user 
utterances had to be narrowed. Ideally, the user should be free to say whatever he wants 
independently of the words used or the syntactic structure chosen. However, the nature of this 
project does not allow PMA to have such a wide flexibility. With this, the user can interact with 
the system with somewhat rigid and limited sentences. The user should question the system 
using utterances similar to the following ones: 
• “Qual é a dose de <nome medicamento> receitada?” 
   (What is the prescribed dosage of <medicine name>?) 
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• “Qual é a frequência de <nome medicamento> receitada?” 
(What is the prescribed frequency of <medicine name>?) 
• “Qual é a via para tomar <nome medicamento>?” 
(What is the route to take <medicine name>?) 
• “Existem restrições para tomar <nome medicamento>?” 
(Are there any restrictions to take <medicine name>?) 
• “Quais são as posologias existentes de <nome medicamento>?” 
(What are the posologies of <medicine name>?) 
• “Quais são as reações adversas de <nome medicamento>?” 
(What are the adverse reactions of <medicine name>?) 
• “Porque razão estou a tomar <nome medicamento>?” 
(Why am I taking <medicine name>?) 
• “Quais são os medicamentos que o médico receitou?” 
(What are the medicines that the doctor prescribed?) 
• “Posso tomar <nome medicamento>?” 
(Can I take <medicine name>?) 
These questions will be interpreted by the system and an appropriate answer will be given, 
making use of the information retrieved from PMA resources. For example, if the patients asks: 
“Quais são os medicamentos que o médico receitou?” (What are the medicines that the doctor 
prescribed?), PMA would list the names of the medicines that were on the prescription, along 
with a counting for the total number of medicines prescribed. When the user utterance is invalid 
or the system does not understand what was said, PMA will retaliate with a random set phrase 
that requests the user to repeat or reformulate the question. 
The system can also promptly react to some basic words present in a normal conversation: 
“sim” (yes), “não” (no), “ajuda-me” (help me), “112”, “adeus” (goodbye) or “obrigado/a” 
(thanks you). These interactions are not dependent of PMA resources as the previous questions. 
For example, “sim” (yes) or “não” (no) are useful for the user to answer some questions that 
PMA uses for confirmation or inquiry. As “ajuda-me” (help me) will trigger a brief explanation 
on the PMA system, “112” will make the system deal an emergency call to the national number 
of emergency 112. If the user wants to close the assistant, he should say “adeus” (goodbye). A 
few courtesy phrases are also triggered if “obrigado/a” (thank you) is said, giving a more 
natural feeling to the interaction. 
The PMA has access to user’s medical prescriptions. This way, information can be more 
reliable and tailored for each patient. The prescription must have the list of prescribed 
medicines along with the prescribed posology. For testing PMA prototypes, a medical 
prescription was simulated. Another feature of PMA includes the production of a medical 
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report, resulting from an inquiry to the user, that allows the healthcare staff that is responsible 
for that patient to be informed when the he does not feel well or has a critical HF symptom. 
A general dialogue task specification, in the form of the task tree presented in Figure 4.1, 
encodes the system's behaviour and allows a first insight into system architecture. Each system 
feature will be explained with more detail in the next section. 
 
 
Figure 4.1: Task tree of PMA.  
4.2. Architecture 
The PMA was developed envisioning a modular architecture, this is, a top-down design. In 
this design strategy, the system consists of small and autonomous modules, each performing 
different functions but altogether working as single structure. This makes the system easier for 
debugging and for latter updating or modification. Having a modular structure is important for a 
conversational assistant, where different tasks are being carried and a specific module could be 
reused in other systems (Mellish & Evans, 2004). 
The three essential modules that comprise the PMA were established as the language 
parser, the dialog manager and the language generator. Both speech recognition and synthesis 
modules allow these crucial components to directly interact with the user, using pre-existent 
speech tools. With this, they are integrated with the remaining components, making a total of 
five modules that compose the PMA system. A schematics overview of the system is shown on 
Figure 4.2. Initially this work was meant to have a special focus on the development of the 
language generation module. However, functional NLU and managing modules are 
indispensable for a system that tries to come nearer to a conversational system. 
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Figure 4.2: Schematics showing the flow between different modules of PMA and its resources. 
4.2.1   Language Parser 
The language parser is responsible for performing a rudimentary processing and 
segmentation of what was perceived by the recognition module. The whole process can be seen 
as a Natural Language Processing and Understanding procedure. 
The initial phases of project development integrated external tools for language 
processing, such as the text taggers JTextPro and TreeTagger. However, due to the need of 
developing PMA on the Android platform and because there are no tools to perform word 
tagging in Portuguese for Android, it was necessary to rebuild this module. A simple routine 
that tokenizes and then categorizes each token of the sentence was implemented. 
The first step is tokenization, this is, breaking the recognized text into meaningful 
elements (tokens) such as sentences and words. For this, a simple tokenizer routine was 
employed, making use of the BreakIterator package in Java. Afterwards, token list is parsed by 
a phrase chunker and a part-of-speech tagger. This syntactic analysis is required so that each 
sentence is segmented and each word is annotated with the corresponding word class and 
lemma. The parsing process identifies all the names and verbs on user utterances in order to 
spot keywords, extract the necessary information and infer the intention of the user. This 
parsing process relies on a grammar and a lexicon which can have a generalized range of words 
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or can be domain-specific. The final prototype uses of a domain-specific lexicon to make 
computation faster and lighter. Furthermore, a more complex sentence processing method was 
not demanded by the current system. 
In summary, the Language parser or NLU module starts to understand what the user says. 
The processed information will then be passed to the dialog manager. 
4.2.2   Dialog Manager 
The dialog manager is responsible for goal analysis and information retrieval. When 
uttered words are tagged and keywords identified, the system tries to bring out the intention of 
what the user said and, accordingly, delineate a goal for what should be communicated in 
response to the user. A set of communicative goals were defined for PMA: EXISTENCE, 
INFORMATION, LIST, PERMISSION, REASON and UNKNOWN. These goals are used in 
an attempt of question classification. By analysing utterances, the system tries to include each 
of the user’s questions inside one of the mentioned attributes. As user utterances must always 
follow a predefined structure, it was settled that the keyword that establishes the goal, and thus 
reveals what the user requests from the system, is the first word of the utterance, in this case 
being an interrogative pronoun or a verb. This way, system performance is simplified and it is 
enough to associate a goal to each of the distinct intentions behind possible user utterances. For 
example, when the user questions the system “Qual é …?” (What is …), he must want to 
retrieve information related to a specific topic and the communicative goal is defined as 
INFORMATION. If the questions goes as “Quais são…?” (What are …), the user would want 
to see listed the attributes of a certain entity and the goal changes to LIST. If “Porque ...?” 
(Why …?) is asked, the user wants a justification and reasoning, and the goal is set to 
REASON. As for a utterance starting with “Posso …?” (Can I …?), the user would like to 
receive permission for something, being PERMISSION defined as the goal. The similar 
happens for the goal EXISTENCE. UNKNOWN is used when the goal could not be detected. 
Finally, when the goal is defined, the system acts according to the type of response that the user 
is expecting. 
Afterwards, depending on the goal, the dialog manager tries to identify, on the list of the 
tokens identified as nouns, a known medicine name and/or one of the featured property names. 
It also checks if there are verbs in the phrase. If yes, the first verb is also selected as a keyword. 
If the goal is defined as INFORMATION, LIST, EXISTENCE or REASON, the dialog 
manager initially looks for the medicine name on the ontology through specific SPARQL 
queries. After that, it will also check the user’s prescription to know if the uttered medicine was 
prescribed by the doctor. If that medication is not prescribed or if that medicine name is not 
valid, the dialog manager performs a Levenshtein Distance iterative routine to assess the 
similarity between two strings, the uttered medicine name and each name of the prescribed 
medicines. The Levenshtein Distance algorithm measures the edit distance, this is, the 
minimum number of single-character edits, such as deletion, insertion, and substitution, 
necessary to change one word into the other. The medicine name that is on the prescription, and 
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showed more similarity with the uttered medicine name, is then suggested to the user: “Não 
quererá dizer <nome semelhante de medicamento>?” (Don’t you mean <similar medicine 
name>?). The user will have to confirm the judgment of the dialog manager by answering yes 
or no. After checking the prescription and validating the medicine name, the dialog manager 
again searches for the necessary information on the ontology. This time the retrieved 
information is the value of the uttered property, such as dosage, frequency, targets, 
administration route or adverse reactions, for the selected medicine with the posology indicated 
on the prescription. This information is then sent to the generation module. 
If the goal was set as PERMISSION, the dialog manager will immediately check if the 
uttered medicine name is present on the medical prescription. According to its findings, it will 
give an appropriate positive or negative answer. If positive, it will also give information about 
the prescribed frequency for that medication. If negative, the system considers strange the fact 
that the user asked if he could take a medicine that is not prescribed. Patients tend to ask to take 
unprescribed medication when they fell unwell. Therefore, the dialog manager identifies a 
secondary intention behind the user’s question and initiates a medical inquiry. The medical 
inquiry was designed on purpose for HF patients. The objective is to assess if the user has one 
of the symptoms that characterizes worsen of HF. Some questions are made by the system such 
as “Tem pés e pernas inchados?” (Do you have swollen feet or legs?) or “Tem falta de ar?” (Do 
you have shortness of breath?). The user must answer “sim” (yes) or “não” (no) accordingly. If 
the patient answers “não” (no) to all the questions, PMA will ask him “Porque não se sente bem 
então?” (Why are you not feeling well then?) so that the user can freely describe its symptoms.  
 
 
Figure 4.3: Example of a medical report generated by PMA. 
 
Figure 4.4: Example of a medical report generated by PMA for a patient with two of the critical 
HF symptoms. 
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If he answered at least two times “sim” (yes), the system will tell the user to contact his 
doctor. Either way, the dialog manager will generate a report with the date, the patient answers 
each medical inquiry question and an observation field. The observation field can contain the 
user description of symptoms or the classification of the symptoms as urgent. An example of 
this medical report which would be sent by email or by message to the user’s healthcare staff 
can be seen in Figure 4.3 and Figure 4.4. 
4.2.3 Natural Language Generator 
According to the selected keywords and the goal defined by the dialog manager, the 
generation module will build appropriate sentences to answer the user. The final objective is not 
only to output informative text but also to produce direct and suitable statements to clarify the 
user without causing any ambiguity. A group of short and simple sentences will then be 
preferred to fewer but large and complex phrases. 
Natural language generation in PMA is language and application-specific. It exploits 
grammar rules and lexicons that are specific to healthcare and medical domains. According to 
the literature, hybrid language generation systems seemed to be more successful and flexible 
(Galley, Fosler-Lussier, & Potamianos, 2001). When acceptable performance can be achieved 
without using complex linguist approaches, and only a few types of sentences are being 
generated, canned text and templates should be sufficient for realization (Reiter & Dale, 
Building Applied Natural Language Generation Systems, 1997). More complex approaches 
should make use of MTT, phrase or feature based methodologies. As consequence, PMA tried 
to implement a hybrid and pratical approach to NLG: simple and typical phrases are generated 
by canned-text and template-based approaches, while sentences requiring more interaction, 
initiative and complexity use a combination of phrase and feature-based methodologies. 
Canned-text was implemented when fixed instructions or direct answers were required. 
For example, when an error occurs, a statement is randomly selected from a list of fixed 
sentences that ask the user to repeat, such as “Não percebi o que disse. Pode repetir por favor?” 
(I did not understand what you said. Can you repeat please?). 
The template based approach was used for fixed sentences containing ‘gaps’ for the 
information that can differ but takes always the same place on the phrase. This was used, for 
instance, with the greetings that depend on the time of the day or while listing the prescribed 
medicines: “O seu medico receitou <número de medicamentos> medicamentos: <nome 
medicamento1> <nome medicamento2> ....” (Your doctor prescribed <number of medicines> 
medicines: <medicine name1> <medicine name2> …). 
Sentence realization includes linguistic and structure realization, where syntactic and 
morphological rules must be applied to build sentences. The sentences that were generated 
using phrase and feature based methods are usually the most complex ones, containing the 
answers that include information from the ontology. Each sentence is specified according to a 
certain phrase pattern, being composed by the following phrase elements: verb, subject, object, 
noun modifier, post-modifier and punctuation. Only the elements verb and punctuation are 
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defined as compulsory components of the phrase. Furthermore, generation is dictated by the 
characteristics of the sentence desired, according to a feature-based methodology. A unique set 
of features, such as negative/affirmative and singular/plural, must be defined to allow the 
sentence to be successfully generated. 
For getting the appropriate word order, as well as gender and number conjugations, the 
generator must make use of a lexicon. The XML lexicon contains the necessary information of 
every word that may be used. Each word element is then characterized by word features like 
category, number, gender, conjugations, etc… The generator analyses this information and 
selects the suitable word for the phrase element that it is building, according to the lexicon and 
the keywords that were recognized. For example, this module automatically chooses the correct 
word form for a selected noun as well as the determinant article that suits it, in accordance with 
gender and number. If the noun has an adjective that characterizes it, it will be integrated in 
conformity. For a verb, the appropriate conjugation is also chosen. Similarly, the object is 
adapted to the verb used, only appearing if the verb is transitive. 
Summarizing module division, the activity diagram from Figure 4.5 shows the flow of 
tasks in the PMA system. 
4.3. Stages of development 
Along the five months of project, the PMA system had three main stages. Each of these 
phases is characterized by a different system prototype, using different tools and features but 
with similar architecture. 
4.3.1 The first prototype 
The initial prototype was a stepping stone into exploring available tools, getting to know 
better the development platforms and making a preliminary design of system modules. This first 
version of PMA was English based, using CMU Sphinx for speech recognition and FreeTTS for 
speech synthesis. These two modules worked very well when integrated with the remaining 
system. Speech interaction in English was successful since FreeTTS presented very good 
synthesis in English and Sphinx allowed a sufficient recognition based on domain specific Java 
speech grammar format (JSGF) grammars. 
This first prototype only had the basic features allowing information retrieval on posology, 
adverse reactions, targets, frequency and administration route. This preliminary prototype could 
only perform canned text generation, this is, fixed strings were outputted according to the goal 
defined. The language parser used JTextPro for tokenization, phrase chunking and part-of-
speech tagging. The linguistic resources included an English dictionary bundled with Sphinx, 
which was slightly extended by adding the information on some domain specific words that 
were missing. This prototype was merely experimental as the ontology was in Portuguese and 
the system only allowed a rigid and very limited Q&A dialog. 
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Figure 4.5: Simplified UML activity diagram of PMA. 
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4.3.2    The second prototype 
On a second stage, the system was developed in Java, also for PC, but this time using 
Brazilian Portuguese and including more features. This version of PMA was the one that took 
longer to develop as it tried to come closer to a mixed-initiative dialogue system, expecting 
some active interaction from both human user and intelligent assistant. 
This version already had all the features comprised along the previous sections. Besides 
the basic Q&A information retrieval on medication dosage, frequency, administration route, 
adverse reactions, restrictions and targets, there is also the possibility of checking prescribed 
medication and know what medicines can be taken. The medical inquiry and consequent 
generation of medical report were firstly included in this prototype. 
For Portuguese, TreeTagger was used by the language parser to do the part-of-speech 
tagging. Both language parsing and generation were built while thinking with the grammar rules 
of European Portuguese, which would be the language of the final prototype. 
Speech synthesis was performed with FurbSpeech while CMU Sphinx, with modified 
grammar files and lexicons, was integrated for recognition. Speech interaction in Brazilian 
Portuguese was not as successful as in English, especial due to the recognition module. As 
explained on the Speech tools section, FurbSpeech synthesis uses MBROLA voices that work 
very well in Brazilian Portuguese but are poorly acceptable in European Portuguese. 
Furthermore, recognition in Portuguese was insufficient due to the inexistence of freely 
available and trained acoustic models for this language. As no other solutions were found for 
this platform, written input was temporarily enabled to facilitate the development and testing of 
the other modules. A few examples of interactions with this version of PMA are present in 
Appendix A. 
4.3.3 The final system 
The final PMA is an adaptation of the second prototype to the Android platform. Using 
Android speech packages and iSpeech android SDK, speech interaction was now successfully 
available in European Portuguese with very good synthesis and good recognition. The 
incorporation of PMA in the Android platform required several changes from the second 
version, although most of the routines and features were maintained. It is also important to note 
that, due to the nature of the speech recognition technology used, domain-specific JSGF 
grammars could not be used for recognition in this prototype. With this, a disadvantage of this 
system, compared with the previous prototypes, was the limitation of Google Voice which does 
not allow to add new vocabulary to be recognized. 
This version has exactly the same features as the previous one. However, the linguistic 
processing had to be reformulated since there are no Portuguese taggers available for Android 
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platforms. A simple lexicon based tagger was built from scratch and, although it presents 
limitations, it was sufficient for the purpose of this language parser. 
The interface of this application tried to be as simple as possible. Some screenshots of the 
application are shown in Figure 4.6. There is a screen to initialize the assistant and, after 
clicking the Start button, the PMA activity, where the dialog will occur, opens. The user has to 
press a button every time he wants to speak and a Google Voice popup window will briefly 
appear for speech recognition. As the dialog proceeds, everything that was said by the user or 
by the system is shown on the screen within a dialog list that can be scrolled up and down. A 
button for stopping the assistant when it is talking was also added. 
4.4. Summary 
Along this chapter, the main features, structure and characteristics of the whole PMA were 
described. The system can give information on medication dosage, frequency, administration 
route, targets, restrictions and adverse reactions, while having the ability to distinguish and 
notify about the medication that was prescribed by the patient’s doctor. It can also perform a 
medical inquiry. PMA arrangement is divided in five modules, being the recognizer, the 
language parser, the dialog manager, the language generator and the synthesizer. Each one has 
its individual tasks but all needed for the system. The project had three phases of development. 
The first was only an experimental approach; the second already included all the features; the 
final one, on the Android platform, was a modification of the second integrated with more 
efficient European Portuguese speech tools. A successful system was then achieved. 
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Figure 4.6: Screenshots with examples of interaction with PMA Android application, featuring 
a) welcome screen, b) Google Voice popup window, c) d) e) examples of dialogue, f) one step 
of the medical inquiry. 
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Chapter 5  
Evaluation and Discussion 
A simple conceptual evaluation was made to assess PMA. This chapter, first, presents the 
evaluation rationale, then the methodologies used and the results obtained. The limitations of 
the developed system, along with some thoughts on the overall project are detailed in the 
second part of this chapter. 
5.1. Evaluation 
The rationale of evaluating systems like PMA relies in collecting real data, analysing it 
and then improving system performance from the flaws identified. Nevertheless, evaluating a 
conversational system, especially understanding and generation modules, is still a challenging 
research problem (Baptist, 2000). The problem of evaluating conversational assistants may lie 
in the limited comparability of results and the impossibility of a full formal evaluation due to 
the heavy dependence on the context where the dialog happens (Artstein, Gandhe, Gerten, 
Leuski, & Traum, 2009).  Although still far from a satisfactory assessment of a conversational 
system, there are several quantitative or qualitative perspectives of analysis that can be made so 
at least a rough judgment of system performance is available. 
 Quantitative evaluation could involve measuring simple dimensions of the system like 
speed and memory requirements or other basic parameters like dialogue length or task success 
rate. Some performance measures for natural language dialogue systems can be found on the 
literature, either for generation, (Gatt & Port, 2009) recognition modules (Smith, 1997) or the 
overall system. (Kamm, Walker, & Litman, 2000) (Danieli & Gerbino, 1995). Temporal 
measurements, such as the time taken to fulfil a task with the system, may not be good 
predictors of user satisfaction (Walker, Boland, & Kamm, 1999). A qualitative evaluation 
seems to be much more difficult to achieve (Baptist, 2000). One can measure the quality of the 
generated strings, system flexibility or its eases of use.  For NLU and NLG modules, the 
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scalability, tailorability and adaptability can also be roughly estimated. A subjective evaluation 
can also appraise system’s ability, for driving the user to his goal, and its robustness due the 
implemented error recovery strategies.  
Even so, the best indication of a system's quality is the collective experience of those who 
use it (Baptist, 2000). Following this idea, testing the usability of PMA with a few senior 
patients would be the best panorama for assessing system feasibility. But as the system is still in 
an early phase of development and tests with older people require special procedures, it was 
decided that usability tests for PMA would not include senior patients for the time being. 
System usability can be mainly assessed either by distributing a questionnaire to the users to 
record their subjective assessment of using the dialogue system or by studying the resulting 
dialogue. The first alternative was here preferred. 
5.1.1   Methodology 
Eleven volunteers, with ages between 22 and 30, participated on the usability study of the 
PMA application, tested on a Samsung Galaxy Nexus GT-I9250 with Android 4.0. The 
usability test consisted in individually asking the user to accomplish two simulated tasks and 
then filling a questionnaire, available in  
Appendix B, to register his subjective perception of his interaction with PMA. The 
objective was not to assess recognition or synthesis modules, but rather the design, task success 
and user satisfaction. Is spoken interaction useful and enjoyable? Does the flow of the 
application match expectations? Is one able to find the desired information? Does the interface 
make sense to the users? 
Before starting the usability test, a brief contextualization of PMA was made to each user. 
It was asked to participants to simulate a heart failure medication scenario. The user would play 
a patient with medication prescribed for heart failure. He was given a list of four medicines that 
he would have at home (Eplerenone, Bisoprolol, Amoxiciline and Paracetamol), not necessarily 
medication that was prescribed. A list of the possible utterances to interact with PMA was also 
given to the user. It was also said that one should only take a medicine that was prescribed by 
the doctor. The user-system interaction was recorded with a camera during the tasks. With this, 
the first task was stated as: 
“You have a fever. What should you do? Can you take one of the medicines you have at 
home? If yes, which one?” 
To complete the task, the user should answer the questions above. This first task would 
require asking a minimum of two questions to PMA. The intention was that the user would 
check with PMA what was prescribed and then ask about the reason for taking each of those 
medicines. He should conclude that he should take Paracetamol because it was prescribed and 
one of its targets is fever. 
For the second task, it was said to the user that: 
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“Your legs are swollen and you feel very tired. Someone said that the unprescribed 
medicine that you have at home can reduce swelling. What should you do? Should you take that 
medicine?” 
This task would require asking a minimum of two questions to PMA as well as answering 
some yes/no questions that the system asks. The objective of this task was for the user to test 
what the system does when he asks if he can take a medicine that is not prescribed. With this, 
the feature of the medical inquiry is explored and the user must have concluded that he should 
contact a doctor immediately due to his symptoms, as PMA advises. 
After completing both tasks, it was given an opportunity to freely explore and use PMA. 
After that, the questionnaire, with 16 statements divided in two sections, was given. Each 
statement was evaluated by the participants with a score between 1 (strongly agree) and 4 
(strongly disagree). The first twelve questions are related to the satisfaction of the user. 
Questions 1, 2, 3, 7 and 12 evaluate usability and likability, while 4 and 5 evaluate coherence 
and appropriateness. Question 6 evaluates naturalness, as 8, 9, 10 and 11 the quality of the 
information given by the system. Questions from 13 to 16 are focused on a senior user 
perspective. To conclude the test, a time for commentaries and suggestions was given. 
The first part of the questionnaire was partially based on the System Usability Scale 
questionnaire (SUS) (Brooke, 1986). Furthermore, the usability test was planned in accordance 
with some of the Fraunhofer guidelines for a smart companion. 
5.1.2   Observations 
During the testing, some difficulties with recognition were observed for the majority of the 
participants, especially related to medicine names such as “eplerenona”. Nevertheless, all the 
users ended up completing both tasks, some of them more easily and faster than others. It was 
also interesting to note that one of the participants had some speech disfluencies and PMA was 
nonetheless able to understand what he said. 
For both tasks, there were several ways of getting the required information, even if some 
of them were straighter and faster than the others. The first task registered an average of 5 
questions per user necessary to achieve the goal. It was observed that, in this task, participants 
spent a lot of time asking other questions unrelated to the objective. The second task presented 
an average of 4 questions and users were more comfortable using the system. A table with more 
information on test data can be seen on Appendix A.II/III. The average scores obtained for each 
point on the questionnaire are showed in Figure 5.1. 
Questions 8 and 13 had the most consensual answers. All the participants felt that PMA 
was easy to use and its interface was pleasant and simple. Overall, quality of information, 
coherence and naturalness were classified as good. There was not much consensus on the 
usability of PMA for older people, especially due to the disparity of results from questions 14 
and 16. It was also registered that the most used question during usability tests was: “Posso 
tomar <nome de medicamento>?” (Can I take <medicine name>?). 
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Overall, user engagement with PMA seemed to be successful. However, the majority of 
the participants said that they felt that PMA was not very intuitive at the beginning. Only after 
some time of interaction with the system, they got to understand how it worked and then it got 
easy to use. Some of them even said that PMA should come initially with some embedded 
instructions. It was also observed that some participants wanted to forcefully talk with the 
system using non contemplated utterances because they were more natural for them. Moreover, 
they also considered that asking directly by the symptoms would be better. For example, they 
wanted to say ‘I have a fever’ or ‘I have a headache’ and PMA would answer with the medicine 
that is prescribed for that symptom. 
 
 
 
 
Figure 5.1: Average score (radius) given by the participants of the usability test to each of the 
16 questionnaire’s statements (perimeter) with the respective attribute that each question 
assesses. 
 
Those who had working experience with senior people seemed to think that older patients 
would not learn how to use PMA quickly, doubting that they would use it for daily-life. In the 
end they said that some modifications should be introduced to further adapt PMA for an older 
audience. 
It was also suggested that it would be interesting to integrate PMA with visual information 
or even a barcode reader for medicine boxes. As some senior patients are not able to read, they 
may not know the name of their medication, written on the medicine packages or their 
prescriptions. Some participants said that some type of information as medication-medication 
interactions would also make the system more helpful. 
The usability test was performed with a small sample size, what is not particularly accurate 
for this type of questionnaire. However, it was enough to have a preliminary idea of how PMA 
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can improve its reliability, helpfulness and usability. The conclusions derived from the usability 
testing will allow refining PMA and should be seen as future work. 
 
5.2. General discussion 
5.2.1   System Limitations 
The developed system presents some limitations that are important to be aware of. Overall, 
PMA lacks in flexibility. The system should be able to understand a wider variety of questions 
and user utterances as well as have a more natural flow of conversation. Android 
implementation brought PMA closer to a mixed-initiative conversational system. Even so, the 
system should still have more initiative to improve user engagement. 
In what relates to speech tools, a limitation is the fact that PMA needs to be connected to a 
network service provider so that speech tools can be used. Unfortunately, this cannot be 
avoided. In fact, this can be an advantage since web services can make the system faster. 
For successful recognition, the user must speak loud, clearly and not too fast. In addition, 
he must only speak when the assistant is silent, otherwise it will not work well. Speech 
recognition does not need to be perfect in order to be effective (Ferguson, Personal Health 
Management Assistant, 2007). Natural human-human conversations also have 
misunderstandings. However, in the current PMA it still occurs too often and affects system 
performance.  The major recognition problem occurs with medicine names. More work could 
be done in the direction of correcting recognition errors through the introduction of a speech 
checker to suggest possible replacements for unrecognized words or to complete questions. 
Currently, PMA only does so when there is a recognition error on a medicine name. 
PMA is also slow to start because it has to load the whole ontology during application 
launching. This would be solved by using web services to get ontology information. Other 
limitation lies in the fact that the information contained in the ontology is extracted from a 
therapeutic compendium book and thus it is not specific for that patient (not personalized) being 
sometimes not so suitable for that user. 
5.2.2   Other considerations 
A reasonable question can be raised for discussion: would PMA be used by older people? 
Some barriers are present in healthcare systems whose target is elderly population. Since older 
patients do not have easy access, technical literacy or familiarity with technology in general, the 
adherence to a computerized-assistant could be poor. Senior patients may view the technology 
as intrusive and not suitable with their lifestyle, offering resistance to the introduction of new 
equipment or new habits. They are also overly attached to their daily routines and it would take 
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a lot of time to feel comfortable with the developed technology. Furthermore, as it was 
concluded from the usability testing, initial training could be required. 
At the NLG level, the complexity of PMA has not yet arrived to a stage where stochastic 
models are needed for generation. Simultaneously, generation is made phrase by phrase, still far 
away from the desired multi-sentence generation. A spell checker for the generated sentences 
could also be implemented to recognize possible structure mistakes or misconceptions from 
users’ queries. 
It is important that PMA remains a medical information-provider rather than a decision-
maker. A conversational system should never be a physician’s substitute. ‘Technology should 
be developed to complement and augment human decision-making’ (Ferguson, Personal Health 
Management Assistant, 2007). Furthermore, it is important to maintain a good granularity for 
the information given by the intelligent assistant. The type and amount of information that is 
appropriated to give may not be the same for every patient. For example, the long list of the 
adverse effects presented on prescribed medicines can pointlessly stress patients, even when 
most of these events are rare or unworthy of attention. Once again, further personalization of 
PMA could avoid causing these unnecessary worries or anxiety. The information that is being 
given to the patient should be adapted and given according to some priorities and to the social 
context of the patient, so that problems of excess of information can be avoided. This 
adjustment can also make the assistant more robust (Jones, Cawsey, & Bentala, 1999). 
5.3. Summary 
A semi-formal evaluation of PMA was performed to assess usability and detect its 
drawbacks so that improvements can be made in the future. Participants were asked to complete 
two tasks with the developed android application and then fill a usability questionnaire. It was 
concluded that users felt that the system was easy to use, simple and had a good interface. 
Participants also gave several suggestions that could help improving PMA. 
The system still presents limitations such as lack of flexibility, need a wireless connection 
to the network, or frequent recognition mistakes. System helpfulness for senior users was also 
discussed. 
 
  
49 
 
Chapter 6  
Conclusions 
After five months of project development, the Personal Medication Assistant culminated 
in an accessible android application that interacts with the user through voice to give 
information about medication.  In this last chapter, a balance of the overall project is made: 
from the evaluation of the initial objectives to the main contributions and the challenges found. 
Possible futures for PMA refinement are also discussed. 
6.1. Final Balance 
The major objective of this project was to come nearer to a conversational assistant: the 
Personal Medication Advisor, a system capable of real-time interaction with a user to help him 
manage his medication through spoken natural language in European Portuguese. Making use 
of speech tools, ontologies and linguistic resources as grammars and lexicons, the final system 
resulted of iterations during three stages of development. The last prototype took the form of an 
Android application where the user can successfully dialog with the system using voice. PMA 
structure is composed by five modules: a recognizer, a language parser, a dialog manager, a 
language generator and a synthesizer. Both recognizer and synthesizer modules are external 
using, in the final PMA version, Google Voice for speech recognition and iSpeech for speech 
synthesis. Natural language understanding was achieved by the language parser using phrase 
chunking, part-of-speech tagging and part of keyword spotting. Single-sentence natural 
language generation was achieved through hybrid methodologies that use simultaneously 
canned-text, template-based and feature-based approaches. 
The PMA application was validated through a usability test. This evaluation wanted to 
assess system’s feasibility, performance and interface, through participants’ opinions after 
completing two tasks and filling a suitable questionnaire. Task objectives were successfully 
achieved. It was concluded that users felt that the system was simple and had a good interface. 
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If this project moves forward, further adaptations for senior users must be made to make PMA 
more helpful and accessible for them. 
Initially, this work was meant to be focused on the development of a language generator 
module capable of producing sentences to be synthesized by existent TTS systems. This 
objective was accomplished and expanded to the incorporation of a language understanding and 
dialog management module with existing ASR systems. This was because functional language 
parsing and managing were needed for achieving any type of conversational assistance. 
With this, all the functionalities planned in the beginning for PMA were achieved. The 
objective of having successful integration between NLU/NLG modules and speech tools was 
also accomplished. As proposed, PMA generates phrases that are coherent, short and easy to 
understand. 
Strengths & weakness 
PMA’s good points are inherent in its motivation, its architecture that aimed to enhance 
modularity, its simplicity and its pleasant interface. The uniqueness of PMA lies on the use of 
ontologies as source of medical information. 
On the other hand, the system still lacks in flexibility, initiative and naturalness, compared 
to users’ expectations of a conversational assistant. The system should require no special 
training for the patients that are going to use it. However, the usability test showed that for 
senior users some features need to be slightly modified to facilitate their first interaction with 
PMA.  
Contributions 
The system was envisioned within a patient centred approach to personal healthcare, 
namely Heart Failure care, so that home-monitoring and treatment quality and efficacy can be 
enhanced. The specific evidence-based information given by PMA can help patients making 
positive behaviour changes. For example, the available information will allow users to know 
possible negative effects of their medication, not being caught completely unaware. The 
simplicity and interactivity of the system will trigger user engagement and hopefully improve 
medication adherence. User satisfaction with PMA will raise their self-consciousness of home 
healthcare and work together with physicians to modify disease outcome. 
Challenges encountered 
During the five months of project, work evolved dynamically as the system was being 
developed.  Nevertheless, major challenges appeared during the different stages of PMA. The 
major obstacle for this project was associated with the lack of freely available speech tools for 
European Portuguese. Several tools were assessed and only the final version was able to have 
successful recognition in this language. Additionally, compared to other languages, European 
Portuguese is still very immature in what is related to natural language research, especially 
NLG. Herewith, generation presented a great challenge. 
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Android implementation of PMA also required an extra effort because it was necessary to 
remodel part of what had already been developed on previous stages. This was also a new 
challenging platform of development, since it was the first contact with it. 
6.2. Future work 
As PMA has limitations, further system development can be made. Due to the complex 
nature of conversational assistants, there are always new features to add or improvements to 
make. This is especially true for natural language understanding and generation. Granularity of 
utterance’s interpretation as well as of the phrase elements that will be part of generated 
sentences can be iteratively diminished and refined. This will gradually result in a more 
complex and enhanced system. Step by step, it should also smooth some of the system 
limitations, such as the lack of flexibility, the lack of initiative or of naturalness. One of these 
steps could be the implementation of statistical and/or stochastic methodologies. Others include 
giving the system the ability to learn common user utterances or underlying intentions, building 
more complete approaches for language generation, or introducing an automated vocabulary 
growth feature. For example, the ability to learn new words is important for interactive systems 
and will increase their flexibility. 
PMA needs to be more tailored to each patient needs. A major improvement at this level 
would be the incorporation of user’s medical history and past medical records. This could be 
complemented with a variety of useful data about the patient. Basic information such as name, 
age, sex, educational level, local background and physiological data (height, weight, blood 
pressure, ….) could be easily provided. Recognition and synthesis of user’s name would also 
make the interaction more natural and personalized. With a great increase of complexity, 
additional intelligent modules could be useful to detect speaker identity, emotional state or even 
degree of motivation. The system could be programmed to use this information and adjust its 
decisions and dialogue accordingly. This attempt to personalize the assistance would be very 
advantageous, although it would present a bigger challenge. 
Further adaption of PMA to senior users is still necessary. From modification of the type 
of utterances allowed to the integration of visual information on the medicine appearance, more 
work can be done to increase acceptance and convenience of PMA for older patients. 
Incorporation with already existent medication reminders or alerts would also boost system 
helpfulness. Moreover, as stated in the introduction, a second and advanced approach to the 
Personal Medication Assistant will have to include contraindications, cautions and drug to drug 
interactions. 
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Appendix A 
Table A. I: Aetiology of heart failure. Source: (European Society of Cardiology, 2012) 
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Figure A.1: Screenshot with an example of PMA interaction during the second stage of 
development. (User utterances in green) 
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Figure A.2: Screenshot with a use case of PMA medical inquiry during the second stage of 
development. (User utterances in green) 
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Table A.II: User information and PMA performance data for the two tasks executed during the usability 
test. 
 
User A B C D E F G H I J K Averages 
 
Gender F F M M M M F M M F M 
 
Age 22 22 30 24 24 22 26 30 26 24 24 24.9 
  
  
Ta
sk
 
I 
Goal Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
 
Time 
elapsed 
(min) 
5 3 5 4 5 3 1 7 4 2 2 3.7 
Nº of 
utterances 5 6 5 4 5 4 3 4 3 6 4 4.5 
 
 
  
Ta
sk
 
II 
Goal Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
 Time 
elapse 
(min) 
3 4 1 2 1 4 1 2 3 3 4 2.5 
Nº of 
utterances 5 6 3 2 1 3 1 2 5 5 6 3.5 
              
 
Daily 
medicines
? 
(number) 
No 
Yes 
(1) No No 
Yes 
(1) 
Yes 
(2) No 
Yes 
(5) No No No  
 
Work with 
seniors? 
(years) 
No No 
Yes 
(½) No No 
Yes 
(½) 
Yes 
(2) 
Yes 
(3) No No No  
  
Table A.III: Average scores and standard deviations for each of the 16 statements of the usability 
questionnaire with the system property they evaluate. 
 
 
Question no. Average score (0-4) Dev. 
Usability 
1 2 0.93 
2 3 0.81 
3 2 0.79 
7 2 0.66 
12 3 0.91 
Coherence 4 2 0.60 5 3 0.69 
Naturalness 6 3 0.68 
Information 
quality 
8 4 0.40 
9 3 0.83 
10 3 0.60 
11 3 0.91 
Usability for 
seniors  
13 3 0.53 
14 3 1.01 
15 3 0.79 
16 3 0.99 
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Appendix B: Usability questionnaire 
Questionnaire - based on the System Usability Scale questionnaire (SUS) 
      User:   Age:   M F 
 
Do you take medication regularly? 
If YES, how many pills per day? 
 
 
In the rating sheet below, please circle the number that most closely matches your feelings about the 
Personal Medication Advisor (PMA) as a user. 
1. In general, I found the system unnecessarily complex. 
Strongly  
disagree 1 2 3 4 
Strongly  
agree 
  
2. In general, I thought the system was easy to use. 
Strongly  
disagree 1 2 3 4 
Strongly  
agree 
 
 
3. I think that I would need the support of a technical person to be able to use this system. 
Strongly 
 disagree 1 2 3 4 
Strongly 
 agree 
 
 
4. I thought there was too much inconsistency in the dialogue. 
Strongly  
disagree 1 2 3 4 
Strongly  
agree 
 
 
5. The dialog I had with the system was coherent. 
Strongly 
 disagree 1 2 3 4 
Strongly 
 agree 
 
 
6. I felt the dialogue with the system was natural. 
Strongly  
disagree 1 2 3 4 
Strongly  
agree 
 
 
7. I found the system very awkward to use. 
Strongly  
disagree 1 2 3 4 
Strongly  
agree 
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Do you usually work for or with senior people? 
If YES, how long have you been working for or with them? 
 
8. The information provided by the system is easy to understand. 
Strongly 
 disagree 1 2 3 4 
Strongly 
 agree 
 
 
9. The system gives error messages that clearly tell me how to fix problems. 
Strongly 
 disagree 1 2 3 4 
Strongly  
agree 
 
 
10. I was able to get useful information using this system. 
Strongly 
 disagree 1 2 3 4 
Strongly 
 agree 
 
 
11.  I quickly could get the information I needed. 
Strongly 
 disagree 1 2 3 4 
Strongly  
agree 
 
 
12. I felt very confident using the system. 
Strongly 
 disagree 1 2 3 4 
Strongly  
agree 
 
Please answer the next questions having a senior user in mind: 
 
13. The interface of this system is pleasant. 
Strongly  
disagree 1 2 3 4 
Strongly  
agree 
 
 
14. Older people would learn to use this system very quickly. 
Strongly 
 disagree 1 2 3 4 
Strongly 
 agree 
 
 
15. This system would help senior patients to understand and manage their medication regimen. 
Strongly 
 disagree 1 2 3 4 
Strongly  
agree 
 
 
16. For those who follow strict medications regimens, I think they would like to use this system frequently. 
Strongly  
disagree 1 2 3 4 
Strongly  
agree 
 
